Newly Developed and Validated Method of Montelukast Sodium Estimation in Tablet Dosage Form by Ultraviolet Spectroscopy and Reverse Phase - High Performance Liquid Chromatography
Authors:
- Selvadurai MuralidharanSMSelvadurai Muralidharan
- Low Jia QiLQLow Jia Qi
- Lai Ting YiLYLai Ting Yi
- Subramani ParasuramanSPSubramani Parasuraman
- Palanimuthu Vasanth RajPRPalanimuthu Vasanth Raj
Open Access
- 1 June 2016
- journal article
- Published by Gulf Index Electronic Publisher in Pharmacology, Toxicology and Biomedical Reports
- Vol. 2 (2) , 27-30
Abstract
Objective: Simple high performance liquid chromatographic (HPLC) and ultraviolet (UV) methods were newly developed and validated for the quantitative estimation of Montelukast (ML) in pharmaceutical dosage form. Material and Methods: HPLC was carried out by reverse phase-HPLC technique on a C 18 column with a good mobile phase consist of 10 mM ammonium acetate and acetonitrile [(pH 5.5 adjusted with orthophosphoric acid (25:75, v/v)]. UV method was developed with the wavelength at 280 nm. Two methods showed good linearity, reproducibility and precision. Both the methods (UV and HPLC) showed no spectral or chromatographic interferences from the tablet excipients. Results: The developed methods were successfully applied to dosage forms. Validation parameters were carried out such as linearity, precision, accuracy, and specificity. The HPLC LOD and LOQ for montelukast were found to be 150 ng/ml and 500 ng/ml. The UV LOD and LOQ for montelukast were found to be 1 µg/ml and 5 µg/ ml. Both the results were statistically differentiated using one-way analysis of variance (ANOVA). The developed and validated economical methods could be applicable for analysis of ML and monitoring of the quality of available drugs.Keywords
This publication has 8 references indexed in Scilit:
- Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodiumJournal of Pharmaceutical and Biomedical Analysis, 2008
- Effect of light and heat on the stability of montelukast in solution and in its solid stateJournal of Pharmaceutical and Biomedical Analysis, 2007
- Dose adjustment in renal impairment: Response from Martindale: the Complete Drug ReferenceBMJ, 2005
- Simultaneous determination of montelukast and loratadine by HPLC and derivative spectrophotometric methodsJournal of Pharmaceutical and Biomedical Analysis, 2003
- Application of pressurized liquid extraction technology to pharmaceutical solid dosage form analysisJournal of Chromatography A, 2002
- Montelukast added to budesonide in children with persistent asthma: A randomized, double-blind, crossover studyThe Journal of Pediatrics, 2001
- Determination of montelukast sodium in human plasma by column-switching high-performance liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Determination of montelukast (MK-0476) and its S-enantiomer in human plasma by stereoselective high-performance liquid chromatography with column-switchingJournal of Pharmaceutical and Biomedical Analysis, 1997